Results 81 to 90 of about 29,949 (204)

Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical Patients

, 2023
Enoxaparin to Prevent Venous Thromboembolism in Older AdultsThis trial of thromboprophylaxis in medically ill, hospitalized older adults did not demonstrate that enoxaparin reduced the risk of symptomatic VTE after 1 month.
Silvy Laporte, Pauline Darbellay Farhoumand, Yves Bleher, Romain Decours, Nicolas Paleiron, Le Gal, Grégoire, Sarah-Lou Guyot, Benhamou, Ygal, Marhic, Gisèle, Paleiron, Nicolas, Daumas, Aurélie, Olivier Sanchez, Karine Lacut, Darbellay Farhoumand, Pauline, De Carvalho, Hugo, Meyer, Guy, Guillaume Armengol, Lacut, Karine, Grégoire Le Gal, Helia Robert-Ebadi, Marc Righini, Emilie Presles, Cogulet, Virginie, Mahé, Isabelle, Isabelle Mahé, Mottier, Dominique, Claire Rousseau Legrand, Righini, Marc, Albert Trinh-Duc, Trinh-Duc, Albert, Philippe Girard, Rousseau Legrand, Claire, Yannick Lambert, Guyot, Sarah-Lou, Decours, Romain, Francis Couturaud, Hugo De Carvalho, Le Henaff, Catherine, Boutreux, Sébastien, Dewi Guellec, Plaisance, Ludovic, Le Moigne, Emmanuelle, Righini, Marc Philip, Guy Meyer, Laporte, Silvy, Reny, Jean-Luc, Patrick Mismetti, Armengol, Guillaume, Catherine Le Henaff, Sanchez, Olivier, Jean-Luc Reny, Ludovic Plaisance, Girard, Philippe, Lambert, Yannick, Ygal Benhamou, Mismetti, Patrick, Dominique Mottier, Virginie Cogulet, Danguy des Deserts, Marc, Marc Danguy des Deserts, Robert-Ebadi, Helia, Guellec, Dewi, Bouchra Lamia, Couturaud, Francis, Sébastien Boutreux, Presles, Emilie, Clémence Cuvelier, Cuvelier, Clémence, Bleher, Yves, Lamia, Bouchra, Gisèle Marhic, Darbellay, Pauline, Emmanuelle Le Moigne, Aurélie Daumas   +73 more
core   +1 more source

Comparative efficacy of certoparin, enoxaparin, and combined thromboprophylaxis on thromboembolic events after glioblastoma resection: a prospective observational study

Scientific Reports
Thromboembolic events (TE) are serious complications following glioblastoma (GBM) resection. This retrospective study analyzed 695 GBM patients (2017–2022, University Hospital Dresden) to assess the impact of different anticoagulant regimens—certoparin ...
Eva Wardenbach, Dino Podlesek, Boshr Alhasan, Ahmed Abouelhamd, Ilker Y. Eyüpoglu, Tareq A. Juratli, Witold H. Polanski   +6 more
doaj   +1 more source

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 9, Page 1219-1233, November 2026.
Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala, Sameer Rao, Manas Gunani, Kajol Shah, Anand V. Kulkarni, Karn Wijarnpreecha, Daniel Q. Huang, Pojsakorn Danpanichkul, Ahmed Al‐Khazraji, Kaveh Hajifathalian, Vivek Lingiah, Paul Gaglio, Nikki Duong, Christine Gerula   +13 more
wiley   +1 more source

Rectus sheath hematoma in patients receiving subcutaneous enoxaparin: A case series of five patients

, 2020
Physicians must acknowledge the potential risk of RSH with enoxaparin. Switching home anticoagulation by enoxaparin upon hospital admission is common, but it may put patients at higher risk for RSH.
Cavadas, Susana, Diogo Mendes, Susana Cavadas, Francisco Batel‐Marques, Penedones, Ana, Batel-Marques, Francisco, Mendes, Diogo, Ana Penedones, Alves, Carlos, Michele Martins, Carlos Alves, Martins, Michele   +11 more
core   +1 more source

Enoxaparin-sodium [PDF]

Reactions Weekly, 2021
  +5 more sources

Effect of enoxaparin on macrophage infiltration into the inflamed colon.

, 2015
(A) Representative immunostaining of F4/80-positive macrophages in in the distal colon from healthy and colitic mice treated with and without enoxaparin. (B) Quantification of macrophages (F4/80+ cells) in the colons.
Sarron Randall-Demllo (776243), Rahul P. Patel (698431), Niall Stewart (698428), Sukhwinder Singh Sohal (317561), Nuri Gueven (134653), Rajaraman D. Eri (755888), Qi Ying Lean (755887), Gregory M. Peterson (564167)   +7 more
core   +1 more source

The Efficacy of Low-Dose Enoxaparin in Psoriasis [PDF]

, 2022
Psoriasis is a frequently encountered inflammatory skin disease with unclear etiology and no curative therapy. Enoxaparin is a low-molecular weight heparin analogue.
Atakan, Nilgün, Demircioğlu, Deniz
core   +1 more source

Intra-Abdominal Hematoma Following Enoxaparin Injection

, 2016
An elderly patient, who was being treated for therapeutic enoxaparin for a couple of days due to suspected deep vein thrombosis, was admitted to hospital following a collapse and severe abdominal pain.
Kin Tong Chung
core   +1 more source

Use of enoxaparin in end-stage renal disease

, 2013
Enoxaparin has become the treatment of choice for various thromboembolic diseases. In most patients with end-stage renal disease (ESRD), prophylactic dosage of enoxaparin does not appear to be associated with an increased bleeding risk and can be used ...
LAI, SILVIA, Bettina Coppola
core   +1 more source

Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2015
Background In the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) trial, apixaban was noninferior to enoxaparin/warfarin in preventing recurrent symptomatic venous thromboembolism (VTE ...
Xianchen Liu, Margot Johnson, Jack Mardekian, Hemant Phatak, John Thompson, Alexander T. Cohen   +5 more
doaj   +1 more source